Arizona runs out of lethal injection drugs: Is this how the death penalty dies?

Arizona drugs shortfall is part of an increasingly poignant national debate that has put the ethics of the death penalty at odds with its practicality.

|
(AP Photo)
Florence state prison, Arizona prison where the nearly two hour execution of Joseph Rudolph Wood took place on July 23, 2014, is photographed in Florence, Ariz. Wood was convicted in the 1989 shooting deaths of Debbie Dietz, and Gene Dietz, at an auto repair shop in Tucson.

Arizona’s admission on Friday that its supply of a drug mixture approved for use in the death penalty has dried up can be tied directly to a growing refusal of US and European pharmaceutical companies – including, last month, Pfizer – to be partners in state-sponsored homicide.

But the upshot of Arizona’s empty cupboard is emblematic of a country increasingly on the fence about the ultimate punishment. Lacking the three-part mixture that makes up the state’s official lethal injection cocktail, “there can be no executions in Arizona in the foreseeable future,” writes Michael Kiefer, in the Arizona Republic.

The admission came as part of a legal review of the 2014 execution of convicted murderer Joseph Rudolph Wood, who took nearly two hours to die. A sedative used in that execution, midazolam, is no longer available to states, and Arizona officials say they also haven’t been able to procure two others – one that’s designed to stop breathing, the other to stop the heart.

Whether or not states can come up with pharmaceutical substitutes, the situation in Arizona is part of an increasingly poignant national debate that has put the ethics of the death penalty at odds with its practicality, raising deep doubts about “the justification for the death penalty itself,” as Supreme Court Justice John Paul Stevens predicted after ruling on a lethal injection case out of Kentucky in 2008.

Now, almost a decade after Justice Stevens’ point, ethical concerns by pharmaceutical companies and federal prohibitions on importing certain drugs from abroad has complicated the process, perhaps to a point of no return. In the past five years alone, the makers of 13 different drugs have blocked their use by states for killing convicts. That means that 20 of the 31 states that impose the death penalty have either formal or informal moratoriums in place, given an inability to procure the necessary drugs.

Meanwhile, public opinion – as shown in polls as well as the frequency of death penalty convictions – has shifted. Fifty-six percent of Americans favored capital punishment in 2015, but that's down from 78 percent just 20 years ago, according to the Pew Research Center.

Last year, the US saw only 49 death sentences imposed, a 33 percent drop from the previous year, and down from a peak of 315 in 1996. Two-thirds of last year’s death sentences came from juries in only 2 percent of US counties, according to the Death Penalty Information Center.

Moreover, fueled by a series of death row exonerations and what many saw as botched executions in the last two years, deeper problems in the state-by-state death penalty system have been increasingly laid bare by circumstances, even as the Supreme Court, with reservations, has continued to uphold the practice.

A number of corrections officials in Oklahoma resigned recently after a grand jury investigation found that some officials acted “flippantly and recklessly” as they attempted to procure the drugs. And several states have been forced to surreptitiously purchase drugs – sometimes using $100 bills so purchases can’t be tracked – from countries such as India.

“In scrambling to find another supplier, several states showed themselves to be more interested in scoring product than in administering the death penalty in a fair, reliable manner,” writes Lincoln Caplan, in the New Yorker. He adds: “… the unsuccessful effort, by one state after another, to carry out lethal injections [fairly and reliably] has made it increasingly clear that states cannot constitutionally perform these types of executions.”

Such realizations have begun to have an impact. "Everywhere you look with the death penalty, there's a problem,” Kathryn Kase, executive director of the Texas Defender Service, told USA Today.

Yet several states are not ready to swear off the sanction, which the Supreme Court found constitutional in 1976.

Missouri, Georgia, and Texas have all managed to carry out executions via lethal injection by using compounding pharmacies, which operate without FDA oversight.

But given the fact that “states will run out of drugs for lethal injections” they “will be faced with the choice of whether to use another method,” Lincoln Caplan, writing in the New Yorker.

To that end, Utah voted last year to bring back the firing squad and Tennessee began preparing for electric chair executions in 2014, in anticipation that the drug supply would be squeezed. A small number of states still allow gas chambers and hanging as options.

But a study by YouGov last year found Americans only support the death penalty if it’s done by lethal injection – which has the patina of a medical procedure – rather than other, more seemingly gruesome, methods.

That leaves a rapidly dwindling number of options for states like Arizona that are determined to carry out the ultimate penalty a jury can bestow.

“States that want to carry out executions have a couple of choices: look for other sources of drugs (such as compound pharmacies), change their method of execution, or decide they’re done with capital punishment,” Robert Dunham, the executive director of the Death Penalty Information Center, told The Christian Science Monitor’s Jason Thomson last month.

Arizona currently has 118 prisoners on death row.

You've read  of  free articles. Subscribe to continue.
Real news can be honest, hopeful, credible, constructive.
What is the Monitor difference? Tackling the tough headlines – with humanity. Listening to sources – with respect. Seeing the story that others are missing by reporting what so often gets overlooked: the values that connect us. That’s Monitor reporting – news that changes how you see the world.

Dear Reader,

About a year ago, I happened upon this statement about the Monitor in the Harvard Business Review – under the charming heading of “do things that don’t interest you”:

“Many things that end up” being meaningful, writes social scientist Joseph Grenny, “have come from conference workshops, articles, or online videos that began as a chore and ended with an insight. My work in Kenya, for example, was heavily influenced by a Christian Science Monitor article I had forced myself to read 10 years earlier. Sometimes, we call things ‘boring’ simply because they lie outside the box we are currently in.”

If you were to come up with a punchline to a joke about the Monitor, that would probably be it. We’re seen as being global, fair, insightful, and perhaps a bit too earnest. We’re the bran muffin of journalism.

But you know what? We change lives. And I’m going to argue that we change lives precisely because we force open that too-small box that most human beings think they live in.

The Monitor is a peculiar little publication that’s hard for the world to figure out. We’re run by a church, but we’re not only for church members and we’re not about converting people. We’re known as being fair even as the world becomes as polarized as at any time since the newspaper’s founding in 1908.

We have a mission beyond circulation, we want to bridge divides. We’re about kicking down the door of thought everywhere and saying, “You are bigger and more capable than you realize. And we can prove it.”

If you’re looking for bran muffin journalism, you can subscribe to the Monitor for $15. You’ll get the Monitor Weekly magazine, the Monitor Daily email, and unlimited access to CSMonitor.com.

QR Code to Arizona runs out of lethal injection drugs: Is this how the death penalty dies?
Read this article in
https://www.csmonitor.com/USA/Justice/2016/0625/Arizona-runs-out-of-lethal-injection-drugs-Is-this-how-the-death-penalty-dies
QR Code to Subscription page
Start your subscription today
https://www.csmonitor.com/subscribe